RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Wells Pharma Fentanyl Citrate Injection Recall

FentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

Updated April 1, 2026

Wells Pharma of Houston is recalling fentanyl citrate injectable solution (NDC 73702-203-65) due to manufacturing quality issues that may affect the drug's safety and efficacy. This is a Class II recall by the FDA.

Is the Wells Pharma of Houston LLC recalled? Yes. This product was recalled by FDA on April 1, 2026. Details below.

What is recalled

Fentanyl Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50 mL (20 mcg per mL), NDC 73702-203-65, manufactured by Wells Pharma of Houston LLC.

Am I affected

You are affected if you have this specific fentanyl injectable product with NDC 73702-203-65. Check the label on your product to verify the NDC number.

What to do right now

Stop using this product immediately. Contact your pharmacy, healthcare provider, or the manufacturer Wells Pharma of Houston LLC to return the drug or receive a replacement.

The hazard

CGMP deviations.

Brands affected

Wells Pharma of Houston LLC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0506-2026
Classification
Class II
Recalled
April 1, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls